Bone cement compositions having fiber-reinforcement and/or increased flowability
View Patent ↗The present invention relates in general to implantable compositions, and method for preparing same, containing a calcium salt-containing component, optionally demineralized bone, a plurality of discrete fibers, optionally a flow additive, and optionally continuous reinforcing fibers or an array of organized fibers in the form of mesh. Advantageously, the discrete fibers have a specific aspect ratio (length/diameter) from about 50:1 to about 1000:1. The addition of a small amount of discrete fibers and/or the continuous reinforcing fibers or fiber mesh can cause drastic increases in certain mechanical properties including flexural strength, flexural toughness, and/or screw pullout strength.
1. An implantable composition comprising:
Solid components comprising (a) a calcium salt-containing component, wherein the calcium salt-containing component comprises one or more of amorphous calcium phosphate, crystalline calcium phosphate, CaHPO 4 , CaHPO 4 .H 2 O, α-Ca 3 (PO 4 ) 2 , α-bar-Ca 3 (PO 4 ) 2 , β-Ca 3 (PO 4 ) 2 , γ-Ca 3 (PO 4 ) 2 , Ca 5 (PO 4 ) 3 OH, Ca 4 O(PO 4 ) 2 , CaP 4 O 11 , α-Ca 2 P 2 O 7 , β-Ca 2 P 2 O 7 , γ-Ca 2 P 2 O 7 , Ca(H 2 PO 4 ) 2 .nH 2 O, where n is a real number from 0 to 5, Ca 8 H 2 (PO 4 ) 6 .5H 2 O, Ca(SO 4 ) 2 , α-Ca(SO 4 ) 2 .1/2H 2 O, or β-Ca(SO 4 ) 2 .1/2H 2 O; or any combination thereof;
(b) from about 1% to about 5% by weight of fibers comprising resorbable homopolymers or copolymers, the fibers having a fiber length of not more than about 15 mm, wherein a fiber surface is modified; and
one or more liquid components.
2. The implantable composition of claim 1 , further comprising demineralized bone.
3. The implantable composition of claim 1 , wherein the ratio of liquid components to solid components is from 0.41 to 0.55.
4. The implantable composition of claim 1 , exhibiting increase in flexure strength over compositions without discrete fibers from 50% to about 900%.
5. The implantable composition of claim 1 , exhibiting increase over composition without discrete fibers in screw pullout strength from 75% to about 800%.
6. The implantable composition of claim 1 , exhibiting increase over composition without discrete fibers in flexural toughness of at least 35- fold.
7. An implantable composition comprising:
(a) a calcium salt-containing component, wherein the calcium salt-containing component comprises one or more of amorphous calcium phosphate, crystalline calcium phosphate, CaHPO 4 , CaHPO 4 .H 2 O, α-Ca 3 (PO 4 ) 2 , α-bar-Ca 3 (PO 4 ) 2 , β-Ca 3 (PO 4 ) 2 , γ-Ca 3 (PO 4 ) 2 , Ca 5 (PO 4 ) 3 OH, Ca 4 O(PO 4 ) 2 , CaP 4 O 11 , α-Ca 2 P 2 O 7 , β-Ca 2 P 2 O 7 , γ-Ca 2 P 2 O 7 , Ca(H 2 PO 4 ) 2 .nH 2 O, where n is a real number from 0 to 5, Ca 8 H 2 (PO 4 ) 6 .5H 2 O, Ca(SO 4 ) 2 , α-Ca(SO 4 ) 2 .1/2H 2 O, or β-Ca(SO 4 ) 2 .1/2H 2 O; or any combination thereof;
(b) a plurality of fibers comprising resorbable homopolymers or copolymers;
(c) fibers comprising an array or mesh of resorbable homopolymer or copolymer fibers; and
(d) demineralized bone.
8. The implantable composition of claim 1 , exhibiting increase in flexural strength over composition without fibers in flexural strength from 50% to about 900%.
9. The implantable composition of claim 7 , exhibiting increase over composition without discrete fibers in screw pullout strength from 75% to about 800%.
10. The implantable composition of claim 7 , exhibiting increase over composition without fibers in flexural toughness of at least 35- fold.
11. An implantable composition comprising:
(a) a calcium salt-containing component, wherein the calcium salt-containing component comprises one or more of amorphous calcium phosphate, crystalline calcium phosphate, CaHPO 4 , CaHPO 4 .H 2 O, α-Ca 3 (PO 4 ) 2 , α-bar-Ca 3 (PO 4 ) 2 , β-Ca 3 (PO 4 ) 2 , γ-Ca 3 (PO 4 ) 2 , Ca 5 (PO 4 ) 3 OH, Ca 4 O(PO 4 ) 2 , CaP 4 O 11 , α-Ca 2 P 2 O 7 , β-Ca 2 P 2 O 7 , γ-Ca 2 P 2 O 7 , Ca(H 2 PO 4 ) 2 .nH 2 O, where n is a real number from 0 to 5, Ca 8 H 2 (PO 4 ) 6 .5H 2 O, Ca(SO 4 ) 2 , α-Ca(SO 4 ) 2 .1/2H 2 O, or β-Ca(SO 4 ) 2 .1/2H 2 O; or any combination thereof; and
(b) a plurality of fibers that are resorbable homopolymers or copolymers wherein ends of the fibers have shapes of beads, balls, dogbone shapes or dumbbell shapes.
12. The implantable composition of claim 11 , further comprising demineralized bone.
13. The implantable composition of claim 11 , further comprising a flow additive.
14. The implantable composition of claim 11 , further comprising reinforcing fibers.
15. The implantable composition of claim 11 , further comprising a radioopaque agent.
16. The implantable composition of claim 11 , further comprising one or more of a drug, carrier, bone ingrowth induction catalyst, antiviral, and antibiotic.
17. The implantable composition of claim 11 , further comprising one or more of a monofilament, multifilament structure, sheet, coating, membrane, screw augmentation, cranial reconstruction and combinations thereof.
18. A method for forming and implanting an implantable fiber-reinforced composite material, comprising:
incorporating a sodium hyaluronate flow additive with a calcium salt containing material to form a flowable calcium salt containing composition;
incorporating a plurality of fibers with the calcium salt containing composition to form a fiber-reinforced calcium salt containing composition;
positioning continuous reinforcing fibers near, around or within a bone void or a bone defect; and
introducing the fiber-reinforced calcium salt containing composition into, onto or proximal to a bone void or bone defect in a manner that at least partially coats or fills the bone void or bone defect and continuous reinforcing fibers.
19. The method of claim 18 further comprising incorporating demineralized bone with the fiber-reinforced calcium salt containing composition.
20. An implantable composition comprising:
(a) a calcium salt-containing component, wherein the calcium salt-containing component is amorphous calcium phosphate, crystalline calcium phosphate, CaHPO 4 , CaHPO 4 .H 2 O, α-Ca 3 (PO 4 ) 2 , α-bar-Ca 3 (PO 4 ) 2 , β-Ca 3 (PO 4 ) 2 , γ-Ca 3 (PO 4 ) 2 , Ca 5 (PO 4 ) 3 OH, Ca 4 O(PO 4 ) 2 , CaP 4 O 11 , α-Ca 2 P 2 O 7 , β-Ca 2 P 2 O 7 , γ-Ca 2 P 2 O 7 , Ca(H 2 PO 4 ) 2 .nH 2 O, where n is a real number from 0 to 5, Ca 8 H 2 (PO 4 ) 6 .5H 2 O, Ca(SO 4 ) 2 , α-Ca(SO 4 ) 2 .1/2H 2 O, or β-Ca(SO 4 ) 2 .1/2H 2 O; or any combination thereof; and
(b) from about 1% to about 5% by weight of discrete fibers that are resorbable homopolymers or copolymers, wherein a fiber texture and/or fiber end is modified to increase pullout resistance.
21. The method of claim 18 , further comprising grinding the calcium salt containing material.
22. The implantable composition of claim 20 , wherein fiber ends have shapes of beads, balls, dogbone shapes or dumbbell shapes.